Trump administration bars use of Medicaid funds for some youth transgender care
Summary
President Trump’s administration announced that Medicaid and the Children’s Health Insurance Program (CHIP) will stop paying for most gender-affirming hormone treatments and surgeries for transgender minors under 19 starting October 13. The policy will still cover mental health care for transgender youth but will gradually end payment for hormone treatments by April 2027.Key Facts
- Medicaid and CHIP will no longer cover gender-affirming surgeries and most hormone treatments for transgender minors under age 19.
- The change will start on October 13, 2024.
- Mental health treatment for transgender youth will continue to be covered.
- Coverage for hormone treatments for those already receiving them will phase out by April 2027.
- President Trump directed Dr. Mehmet Oz, head of the Centers for Medicare and Medicaid Services, to implement the change.
- At least 27 states have banned gender-affirming care for those under 18, and many hospitals have stopped offering these treatments.
- Medical groups like the American Medical Association support access to gender-affirming care, while some groups question surgery benefits for minors.
- The administration has proposed other policies restricting transgender rights, including bans on transgender athletes in girls’ and women’s sports and limiting passport gender options.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
